Bharat Biotech Rejects Study That Claimed Covaxin Less Effective Than Covishield

New Delhi, June 09: Bharat Biotech has categorically rejected a recent study that claimed that Covaxin is significantly less effective against the B.1.617.2 variant, the strain largely responsible for the ferocious second wave of the pandemic in the country.

The company also dismissed claims that its Covaxin is less effective than Serum Institute of India’s Covishield.




Cross Town News is the no. 1 Weekly Newspaper and Online News Portal in J&K in term of serious News. The rugged Newspaper & Portal is with a substantial difference to read and presence to feel. This newspaper has a vision to deliver the real side of truth to the public . Since it’s inception in 2013 March, It has become No. 1 News medium for people of J&K. Cross Town News has a mission to deliver high quality news across the nation within fraction of time.

Subscribe Now

Subscribe to our weekly Newsletter.